ArticleMedicine2026
Predictive value of high-resolution computed tomography radiomics for assessing the invasiveness of pulmonary adenocarcinoma presenting as ground-glass nodules: A retrospective study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This study aims to explore the predictive value of radiomics based on high-resolution computed tomography for assessing the invasiveness of pulmonary adenocarcinoma manifested as ground-glass nodules (GGNs). We collected data from 360 GGNs cases confirmed as pulmonary adenocarcinoma by surgical pathology at the First Affiliated Hospital of Chengdu Medical College between January 2019 and December 2023. Clinical information and imaging features were also gathered. The cases were divided into a noninvasive group with 127 cases (35.3%) and an invasive lesion group with 233 cases (64.7%). A total of 279 GGN patients were randomly divided into a training group (195 cases) and a test group (84 cases), with a 7:3 ratio, and 81 cases were included in the validation group. Based on the selected clinical features and radiomics features of GGN, a radiomics model, a clinical model, and a combined clinical-radiomics model were constructed using LASSO and multivariate Logistic Regression. The predictive performance of the 3 models was evaluated and compared using the area under the curve, decision curve analysis, and DeLong test. In the validation set, the area under the curves for the radiomics model (using 29 radiomics features), the clinical model (mean length and air bronchogram), and the combined clinical-radiomics model were 0.856, 0.901, and 0.911, respectively. Decision curve analysis and DeLong's test indicated that the combined clinical-radiomics model has higher value in predicting the invasiveness of GGNs than the other 2 models. The combined clinical-radiomics model demonstrates good performance in predicting the invasiveness of pulmonary adenocarcinoma presenting as GGNs. It has the potential to provide effective imaging methods for patients planning precise treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.